Tag: Cisplatin

Over 200 medications are known to be ototoxic, with some causing temporary and others causing permanent hearing and balance issues. This guide helps answer what drug causes most hearing impairment by examining the specific types and associated risks of ototoxic medications.

With platinum-based drugs like cisplatin used in almost 50% of chemotherapy patients, understanding their mechanism is crucial for modern oncology. Is cisplatin chemotherapy or immunotherapy, and how does this foundational drug fit into the era of advanced cancer treatment options like immunotherapy?

Up to 84% of patients receiving platinum-based chemotherapy like cisplatin may experience ototoxicity, with many reporting tinnitus. A common question for these individuals is, **can cisplatin cause tinnitus?** The answer is yes, as it is a well-documented and significant side effect of the medication.

In a pilot study involving patients receiving cisplatin chemotherapy, intravenous lorazepam was found to be beneficial, with 46% of participants reporting no recall of the chemotherapy process. This demonstrates that not only **can you take lorazepam with cisplatin**, but the combination has been effectively used in clinical practice for years to manage treatment-related anxiety, nausea, and vomiting.

According to the Vestibular Disorders Association, drugs that are toxic to the inner ear, or ototoxic, are known to cause vestibular toxicity and balance issues. This can result in debilitating symptoms like vertigo, dizziness, and oscillopsia. Understanding **what drugs cause vestibular toxicity** is vital for both patients and healthcare providers to manage risks and improve outcomes.

Over 200 medications are known to be ototoxic, capable of damaging the inner ear and causing hearing loss or balance issues. The question of what is the most ototoxic drug is complex, with certain potent chemotherapies and antibiotics posing the highest risk for irreversible harm to the auditory system. Understanding which drugs are most dangerous and why is critical for patient safety and effective monitoring.

Over 90% of older adults use at least one medication with potential ototoxic (harmful to hearing) side effects. In this context, understanding the safety of supplements is crucial. Far from being harmful, research suggests Coenzyme Q10 (CoQ10) is not ototoxic and may even protect hearing.

Up to 50% of patients treated with certain injectable medicines for drug-resistant tuberculosis may develop permanent hearing loss [1.6.5]. Understanding **what is the mechanism of drug-induced ototoxicity** is crucial for mitigating this widespread risk associated with over 600 different medications [1.2.2].

Uniplatin is a brand name for cisplatin, a widely used chemotherapy agent. This medicine belongs to the class of alkylating agents and is used to treat various types of advanced or metastatic cancers, including ovarian and testicular cancer. Its purpose is to interfere with the DNA of rapidly dividing cancer cells, ultimately causing their death.

First approved in the late 1970s, the chemotherapy drug Platinol, with its active ingredient cisplatin, has been a cornerstone of cancer treatment. So, **What class of drug is Platinol** and how does it work to combat malignant cells? It is primarily classified as an alkylating agent and is also known as a platinum analog.